Doravirine/Islatravir
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Doravirine/Islatravir, covering 2023-02-24 to 2026-02-20. Get the full timeline:
Most recent: Clinical Trial Update: A Study of Doravirine/Islatravir in Healthy Lactating Females (MK-8591A-061) [Phase 1]